RNA vs MAMK

Comparison between Atrium Therapeutics Inc (RNA, Company) and MaxsMaking Inc - Class A (MAMK, Company).

RNA is from the Healthcare sector, while MAMK is from the Industrials sector.

RNA vs MAMK - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	RNA(COMPANY)	MAMK(COMPANY)
Market Cap	$217M	$216M
Max Drawdown	30.17%	46.61%
Sharpe Ratio	-0.87	1.58
5Y Beta	0.99	-0.11
Industry	Biotechnology	Conglomerates
P/E Ratio	N/A	109081.93
Debt to Equity	0.00%	35.21%
Free Cash Flow Yield	0.00%	-2.47%

Market Cap

Winner

RNA

$217M

MAMK

$216M

Max Drawdown

Winner

RNA

30.17%

MAMK

46.61%

Sharpe Ratio

RNA

-0.87

Winner

MAMK

1.58

5Y Beta

RNA

0.99

Winner

MAMK

-0.11

Industry

RNA

Biotechnology

MAMK

Conglomerates

P/E Ratio

RNA

N/A

MAMK

109081.93

Debt to Equity

Winner

RNA

0.00%

MAMK

35.21%

Free Cash Flow Yield

Winner

RNA

0.00%

MAMK

-2.47%

RNA vs MAMK - Historical Returns

Returns include dividend reinvestment.

Period	RNA	MAMK
1 month	-2.24%	+0.00%
3 months	+2.76%	+0.00%
6 months	N/A	+0.00%
1 year	N/A	+252.30%
Max(CAGR)	-39.52%	+277.87%

RNA

-2.24%

Winner

MAMK

+0.00%

Winner

RNA

+2.76%

MAMK

+0.00%

RNA

N/A

MAMK

+0.00%

RNA

N/A

MAMK

+252.30%

Max(CAGR)

RNA

-39.52%

Winner

MAMK

+277.87%

RNA vs MAMK - Annual Returns (2025 - 2026)

Returns include dividend reinvestment.

Year	RNA	MAMK
2026	-14.17%	+0.00%
2025	N/A	+252.30%

RNA vs MAMK Drawdown Comparison

The maximum drawdown for RNA was -30.17%, occurring on Jun 8, 2026. This drawdown has not yet recovered.

The maximum drawdown for MAMK was -46.61%, occurring on Aug 13, 2025. Recovery took 78 trading sessions.

The current RNA drawdown is -23.46%. The current MAMK drawdown is -4.62%.

Rank	RNA	MAMK
#1	-30.17% Mar 4, 2026 - Jun 8, 2026	-46.61% Jul 7, 2025 - Oct 24, 2025
#2	N/A	-34.97% Oct 24, 2025 - Nov 3, 2025
#3	N/A	-5.93% Nov 7, 2025 - Nov 11, 2025
#4	N/A	-4.62% Nov 12, 2025 - Nov 14, 2025